Acceptance Based Coping Skills for Hispanic/Latino Military Patients With Type 2 Diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial tests a values-based coping program delivered via telehealth to Hispanic/Latino military patients with type 2 diabetes who have suboptimal glycemic control. The 10-week ABaCo Skills Program includes seven online lessons and is led by a bilingual English-Spanish health coach. The study aims to see if ABaCo improves diabetes care and to understand barriers and facilitators for implementing the program in a military treatment setting. It also assesses feasibility and acceptability for patients and clinics. The lead sponsor is Baylor College of Medicine, with collaborators including the American Diabetes Association and military medical centers, and the study site is Brooke Army Medical Center in San Antonio, TX.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients ages 18-70
* Diagnosis of T2DM
* Current HbA1c (drawn within 6 months) of 7% or greater (may be taking oral agents or injectables for diabetes control)
* Evidence of avoidance coping (score \<48.4 \[published mean\] on the Acceptance and Action Diabetes Questionnaire) or poor self-management skills (score \< published mean on 2+ subscales of the Summary of Diabetes Self-Care, Activities)
* Self-described as Hispanic/Latino/Latina/Latinx
* Preferred language of English or Spanish, (g) receiving care at the study site clinic.

Exclusion Criteria:

* End-stage renal disease (on dialysis)
* A medical condition or life circumstance that would contraindicate participation
* Proliferative diabetic retinopathy precluding participation
* Inability to read/comprehend the informed consent process or study instructions
* Pregnant or planning to become pregnant in the next 6 months.

Where it's running

• Brooke Army Medical Center
  San Antonio, Texas, United States Recruiting

Study contacts

• Principal investigator: Kathryn E Kanzler, PsyD — Baylor College of Medicine
• Study coordinator: Amanda Leal
• Email: amanda.leal3.ctr@health.mil
• Phone: 240-673-8951

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Acute Blood Flow Restriction Walking in Type 2 Diabetes

  This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT07928531

• Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin

  This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.

  Recruiting Medical University of Bialystok · Bialystok · NCT07919236

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses

  This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.

  Recruiting at 2 sites German Institute of Human Nutrition · Berlin and 1 other locations · NCT07888257

• Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar

  This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.

  Recruiting German Institute of Human Nutrition · Potsdam, Potsdam-Rehbrücke · NCT07868601

• Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes

  This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.

  Recruiting at 2 sites Phase 1 Novo Nordisk A/S · Glendale, California and 1 other locations · NCT07868354

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.